Janux Therapeutics JANX
NASDAQ JANX
$20.24 +0.44 (+2.22%)
As of: Sep 4, 2026 · 3:59 PM EDT

Janux Therapeutics (JANX) Prepaid Assets (2020 - 2026)

Janux Therapeutics (JANX) posted quarterly Prepaid Assets of $893000.0 for Q1 2026, down 90.29% year-over-year from $9.2 million in Q1 2025, and down 51.83% quarter-over-quarter from $1.9 million in Q4 2025.

Analysis

Janux Therapeutics (JANX) Prepaid Assets (2020 - 2026) Analysis & Trends

Janux Therapeutics (JANX) has reported Prepaid Assets for 7 consecutive years, with $893000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets fell 90.29% year-over-year to $893000.0; the TTM figure through Mar 2026 stood at $893000.0 (down 90.29% YoY), while the FY2025 annual figure was $1.9 million, down 21.24% from the prior year.
  • Prepaid Assets slipped to $893000.0 in Q1 2026 per JANX's latest filing, from $1.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $9.5 million in Q2 2025 and bottomed at $893000.0 in Q1 2026.
  • Historically, Prepaid Assets has averaged $5.1 million across 5 years, with a median of $5.1 million in 2022.
  • Annual changes were most pronounced in 2025 — Prepaid Assets jumped 398.54% — and 2026, when it slumped 90.29%.
  • Janux Therapeutics' Prepaid Assets stood at $5.4 million in 2022, then sank by 57.26% to $2.3 million in 2023, then grew by 1.55% to $2.4 million in 2024, then declined by 21.24% to $1.9 million in 2025, then sank by 51.83% to $893000.0 in 2026.
  • Business Quant data shows JANX's Prepaid Assets at $893000.0 in Q1 2026, $1.9 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Janux Therapeutics 1.27 Bn 1.27 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.28 Mn
Mar 31, 2026 10.66 Mn
Dec 31, 2025 9.32 Mn
Sep 30, 2025 9.09 Mn
Jun 30, 2025 9.54 Mn
Mar 31, 2025 9.19 Mn
Dec 31, 2024 8.49 Mn
Sep 30, 2024 8.29 Mn
Jun 30, 2024 8.15 Mn
Mar 31, 2024 6.38 Mn
Dec 31, 2023 5.21 Mn
Sep 30, 2023 5.48 Mn
Jun 30, 2023 6.01 Mn
Mar 31, 2023 3.77 Mn
Dec 31, 2022 5.42 Mn
Sep 30, 2022 5.07 Mn
Jun 30, 2022 3.77 Mn
Mar 31, 2022 3.45 Mn
Dec 31, 2021 2.05 Mn
Sep 30, 2021 2.08 Mn